AHB
BIIB icon

Abner Herrman & Brock’s Biogen BIIB Stock Holding History

Abner Herrman & Brock’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,921
Closed -$3.67M – 117
2020
Q3 		$3.67M Buy
12,921
+4,400
+52% +$1.23M 0.62% 45
2020
Q2 		$2.28M Buy
8,521
+409
+5% +$123K 0.41% 49
2020
Q1 		$2.57M Buy
8,112
+110
+1% +$33.4K 0.58% 41
2019
Q4 		$2.37M Buy
+8,002
New +$2.22M 0.35% 48

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Abner Herrman & Brock's BIIB Position: Q4 2020 in Review

Abner Herrman & Brock sold out of Biogen (BIIB) in Q4 2020, closing a stake of 12,921 shares — an estimated $3.67M sold.

Abner Herrman & Brock first reported a position in BIIB in Q4 2019 and held it in 4 quarters. The position peaked at $3.67M in Q3 2020. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Abner Herrman & Brock reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Abner Herrman & Brock sold 12,921 Biogen shares in Q4 2020, an estimated $3.67M.
  • Abner Herrman & Brock first reported a position in Biogen in Q4 2019 and held it in 4 quarters.
  • Abner Herrman & Brock's Biogen position peaked at $3.67M in Q3 2020.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Abner Herrman & Brock's 13F filing for Q4 2020, filed 12 Jan 2021.